🇺🇸 FDA
Patent

US 10668082

Vaginal inserted estradiol pharmaceutical compositions and methods

granted A61KA61K2300/00A61K31/565

Quick answer

US patent 10668082 (Vaginal inserted estradiol pharmaceutical compositions and methods) held by Compass Therapeutics LLC expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Compass Therapeutics LLC
Grant date
Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2300/00, A61K31/565, A61K31/57, A61K47/14